Literature DB >> 8661974

Effects of androgens on subpopulations of the human osteosarcoma cell line SaOS2.

C H Kasperk1, K Faehling, I Börcsök, R Ziegler.   

Abstract

Previously, we showed that androgens stimulate murine and human osteoblast-like cell proliferation and differentiation by mechanisms involving increased responses to mitogenic growth factors (GF) and increased GF production. To explain this dual action of androgens on primary osteoblastic cell populations we advanced the hypothesis that androgens exert differential effects on osteoblastic subpopulations. We subcloned a human osteosarcoma cell line (SaOS2) into subpopulations expressing high (HAS) and low (LAS) levels of alkaline phosphatase (ALP). The obtained subclones differed significantly in their ALP production and expressed a high and low ALP phenotype, respectively, for the entire experimental period. Dihydrotestosterone (DHT) increased specific ALP activity and type-I procollagen peptide secretion in both HAS and LAS. DHT pretreatment enhanced the mitogenic action of basic fibroblast growth factor (bFGF) and insulinlike growth factor 2 (IGF2) only in HAS. The enhanced mitogenic effect of IGF2 in HAS after DHT pretreatment was associated with increased IGF2-receptor mRNA levels. Therefore, we conclude that androgens exert their osteoanabolic action (1) by stimulating differentiated functions of osteoblastic cells with a high and a low ALP phenotype, and (2) via increased growth factor receptor expression and thereby enhancing mitogenic growth factor responses only in HAS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661974     DOI: 10.1007/bf02509388

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  40 in total

Review 1.  Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation.

Authors:  G S Stein; J B Lian; T A Owen
Journal:  FASEB J       Date:  1990-10       Impact factor: 5.191

2.  Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix.

Authors:  T A Owen; M Aronow; V Shalhoub; L M Barone; L Wilming; M S Tassinari; M B Kennedy; S Pockwinse; J B Lian; G S Stein
Journal:  J Cell Physiol       Date:  1990-06       Impact factor: 6.384

3.  Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties.

Authors:  S B Rodan; Y Imai; M A Thiede; G Wesolowski; D Thompson; Z Bar-Shavit; S Shull; K Mann; G A Rodan
Journal:  Cancer Res       Date:  1987-09-15       Impact factor: 12.701

4.  Identification of androgen receptors in normal human osteoblast-like cells.

Authors:  D S Colvard; E F Eriksen; P E Keeting; E M Wilson; D B Lubahn; F S French; B L Riggs; T C Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women.

Authors:  A G Need; M Horowitz; A Bridges; H A Morris; B E Nordin
Journal:  Arch Intern Med       Date:  1989-01

6.  Insulinlike growth factor II and transforming growth factor beta regulate collagen expression in human osteoblastlike cells in vitro.

Authors:  D D Strong; A L Beachler; J E Wergedal; T A Linkhart
Journal:  J Bone Miner Res       Date:  1991-01       Impact factor: 6.741

7.  Characterization of a human osteoblastic osteosarcoma cell line (SAOS-2) with high bone alkaline phosphatase activity.

Authors:  E Murray; D Provvedini; D Curran; B Catherwood; H Sussman; S Manolagas
Journal:  J Bone Miner Res       Date:  1987-06       Impact factor: 6.741

8.  Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells.

Authors:  M A Aronow; L C Gerstenfeld; T A Owen; M S Tassinari; G S Stein; J B Lian
Journal:  J Cell Physiol       Date:  1990-05       Impact factor: 6.384

9.  Influence of DNA replication inhibition on expression of cell growth and tissue-specific genes in osteoblasts and osteosarcoma cells.

Authors:  M Kockx; L McCabe; J L Stein; J B Lian; G S Stein
Journal:  J Cell Biochem       Date:  1994-01       Impact factor: 4.429

10.  Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase.

Authors:  A M Parfitt; L S Simon; A R Villanueva; S M Krane
Journal:  J Bone Miner Res       Date:  1987-10       Impact factor: 6.741

View more
  5 in total

1.  The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis.

Authors:  Peng Chen; Shao-jin Wang; Hong-bo Wang; Peng Ren; Xi-qian Wang; Wen-guang Liu; Wan-li Gu; Dong-qing Li; Ting-guo Zhang; Cheng-jun Zhou
Journal:  J Mol Histol       Date:  2011-11-01       Impact factor: 2.611

2.  Pathogenesis of Osteoporosis.

Authors:  Sundeep Khosla
Journal:  Transl Endocrinol Metab       Date:  2010-04

Review 3.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

4.  Stanozolol promotes osteogenic gene expression and apposition of bone mineral in vitro.

Authors:  Giulia Ghiacci; Simone Lumetti; Edoardo Manfredi; Daniele Mori; Guido Maria Macaluso; Roberto Sala
Journal:  J Appl Oral Sci       Date:  2018-11-08       Impact factor: 2.698

5.  The effect of oxandrolone treatment on human osteoblastic cells.

Authors:  Lian Xiang Bi; Kristine M Wiren; Xiao-Wei Zhang; Gisele V Oliveira; Gordon L Klein; Elgene G Mainous; David N Herndon
Journal:  J Burns Wounds       Date:  2007-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.